Evolution of Animal Models of Atopic Dermatitis

  • Ichiro KatayamaEmail author
  • Kohsuke Yamaga
  • Hiroyuki Murota


Historically, several atopic dermatitis (AD) models have been introduced and applied for the understanding of human AD and evaluation of the clinical effect of new drugs.

After the establishment of transgenic technology, several transgenic or knockout mouse lines expressing atopic dermatitis-like phenotypes have been reported with promising results. However, it remains unclear as to whether Th2-type cytokines, IL-4, IL-5, or IL-13, play an essential role in the induction of the IgE-mediated reaction or if impaired skin barrier functions with abnormal itch perception play a more fundamental role in human atopic dermatitis.

Another point of discussion is whether IgE antibody itself induces spongiotic eczematous reactions occasionally observed in acute phases of human atopic dermatitis.


Atopic dermatitis Animal model Monoclonal IgE antibody Transgenic/knockout mouse 


  1. 1.
    Holloway JW, Yang IA, Holgate ST. Genetics of allergic disease. J Allergy Clin Immunol. 2010;125(Suppl 2):S81–94.CrossRefPubMedGoogle Scholar
  2. 2.
    Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci. 2009;122:1285–94.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Baurecht H, Irvine AD, Novak N, Illig T, Buhler B, Ring J, et al. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol. 2007;120:1406–12.CrossRefPubMedGoogle Scholar
  5. 5.
    Nomura T, Akiyama M, Sandilands A, Nemoto-Hasebe I, Sakai K, Nagasaki A, Ota M, Hata H, Evans AT, Palmer CN, Shimizu H, McLean WH. Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan. J Invest Dermatol. 2008;128:1436–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Henderson J, Northstone K, Lee SP, Liao H, Zhao Y, Pembrey M, Mukhopadhyay S, Smith GD, Palmer CN, McLean WH, Irvine AD. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol. 2008;121:872–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Weidinger S, O'Sullivan M, Illig T, Baurecht H, Depner M, Rodriguez E, Ruether A, Klopp N, Vogelberg C, Weiland SK, WH ML, von Mutius E, Irvine AD, Kabesch M. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol. 2008;121:1203–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Marenholz I, Nickel R, Rüschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, Grüber C, Lau S, Worm M, Keil T, Kurek M, Zaluga E, Wahn U, Lee YA. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol. 2006;118:866–71.CrossRefPubMedGoogle Scholar
  9. 9.
    Hill LW, Sulzberger MB. Evolution of atopic dermatitis. Arch Dermatol Syphilol. 1935;32:451–63.CrossRefGoogle Scholar
  10. 10.
    Andersen RM, Thyssen JP, Maibach HI. Qualitative vs. quantitative atopic dermatitis criteria–in historical and present perspectives. J Eur Acad Dermatol Venereol. 2016;30:604–18.CrossRefPubMedGoogle Scholar
  11. 11.
    Grewe M, Bruijnzeel-Koomen CA, Schöpf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, Krutmann J. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today. 1988;19:359–61.CrossRefGoogle Scholar
  12. 12.
    Bieber T. Fc epsilon RI on human Langerhans cells: a receptor in search of new functions. Immunol Today. 1994;15:52–3.CrossRefPubMedGoogle Scholar
  13. 13.
    Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol. 2000;115:640–6.CrossRefPubMedGoogle Scholar
  14. 14.
    Masuoka M, Shiraishi H, Ohta S, Suzuki S, Arima K, Aoki S, Toda S, Inagaki N, Kurihara Y, Hayashida S, Takeuchi S, Koike K, Ono J, Noshiro H, Furue M, Conway SJ, Narisawa Y, Izuhara K. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest. 2012;122:2590–600.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt RR, Bazan F, Kastelein RA, Liu YJ. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3:673–80.CrossRefPubMedGoogle Scholar
  16. 16.
    Ray MC, Tharp MD, Sullivan TJ, Tigelaar RE. Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies. J Immunol. 1983;131:1096–102.PubMedGoogle Scholar
  17. 17.
    Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest. 1998;101:1614–22.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Yamamoto M, Haruna T, Yasui K, Takahashi H, Iduhara M, Takaki S, Deguchi M, Arimura A. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. Allergol Int. 2007;256:139–48.CrossRefGoogle Scholar
  19. 19.
    Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, Shiohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol. 1997;159:2484–91.PubMedGoogle Scholar
  20. 20.
    Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol. 1997;9:461–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Butler JM, Peters JE, Hirshman CA, White CR Jr, Margolin LB, Hanifin JM. Pruritic dermatitis in asthmatic basenji-greyhound dogs: a model for human atopic dermatitis. J Am Acad Dermatol. 1983;8:33–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Tepper RI, Levinson DA, Stanger BZ, Campos-Torres J, Abbas AK, Leder P. L-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell. 1990;62:457–67.CrossRefPubMedGoogle Scholar
  23. 23.
    Konishi H, Tsutsui H, Murakami T, Yumikura-Futatsugi S, Yamanaka K, Tanaka M, Iwakura Y, Suzuki N, Takeda K, Akira S, Nakanishi K, Mizutani H. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci U S A. 2002;99:11340–5.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A, Comeau MR, Campbell DJ, Ziegler SF. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med. 2005;202:541–9.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Imai Y, Yasuda K, Sakaguchi Y, Haneda T, Mizutani H, Yoshimoto T, Nakanishi K, Yamanishi K. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci U S A. 2013;2110:13921–6.CrossRefGoogle Scholar
  26. 26.
    Ewald DA, Noda S, Oliva M, Litman T, Nakajima S, Li X, Xu H, Workman CT, Scheipers P, Svitacheva N, Labuda T, Krueger JG, Suárez-Fariñas M, Kabashima K, Guttman-Yassky E. Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling. J Allergy Clin Immunol. 2016;139(2):562–71.CrossRefPubMedGoogle Scholar
  27. 27.
    Mukai K, Matsuoka K, Taya C, Suzuki H, Yokozeki H, Nishioka K, Hirokawa K, Etori M, Yamashita M, Kubota T, Minegishi Y, Yonekawa H, Karasuyama H. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity. 2005;23:191–202.CrossRefPubMedGoogle Scholar
  28. 28.
    Moniaga CS, Egawa G, Kawasaki H, Hara-Chikuma M, Honda T, Tanizaki H, Nakajima S, Otsuka A, Matsuoka H, Kubo A, Sakabe J, Tokura Y, Miyachi Y, Amagai M, Kabashima K. Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. Am J Pathol. 2010;176:2385–93.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Fujii M, Shimazaki Y, Muto Y, Kohno S, Ohya S, Nabe T. Dietary deficiencies of unsaturated fatty acids and starch cause atopic dermatitis-like pruritus in hairless mice. Exp Dermatol. 2015;24:108–13.CrossRefPubMedGoogle Scholar
  30. 30.
    Katayama I, Tanei R, Nishioka K, Dohi Y. Induction of eczematous skin reaction in experimentally induced hyperplastic skin of BALB/c mice by monoclonal anti-DNP-IgE antibody: possible implication for skin lesion formation in atopic dermatitis. Int Arch Allergy Appl Immunol. 1990;93:148–54.CrossRefPubMedGoogle Scholar
  31. 31.
    Yokozeki H, Ghoreishi M, Takagawa S, Takayama K, Satoh T, Katayama I, Takeda K, Akira S, Nishioka K. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med. 2000;191:995–1004.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006;7:535–47.CrossRefPubMedGoogle Scholar
  33. 33.
    Shimada SG, LaMotte RH. Behavioral differentiation between itch and pain in mouse. Pain. 2008;139:681–7.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Tokumasu R, Yamaga K, Yamazaki Y, Murota H, Suzuki K, Tamura A, Bando K, Furuta Y, Katayama I, Tsukita S. Dose-dependent role of claudin-1 in vivo in orchestrating features of atopic dermatitis. Proc Natl Acad Sci U S A. 2016;113:E4061–8.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Hayashi S, Matsuda H, Okumura K, Ra C. Mouse Langerhans cells do not express the high-affinity receptor for IgE. Arch Dermatol Res. 1999;291:241–3.CrossRefPubMedGoogle Scholar
  36. 36.
    Turner H, Kinet JP. Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature. 1999;402(6760 Suppl):B24–30.CrossRefPubMedGoogle Scholar
  37. 37.
    Mitchell EB, Crow J, Chapman MD, Jouhal SS, Pope FM, Platts-Mills TA. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet. 1982;1(8264):127–30.CrossRefPubMedGoogle Scholar
  38. 38.
    Matsunaga T, Katayama I, Yokozeki H, Nishioka K. ICAM-1 expression on keratinocytes in mechanically-injured skin of a patient with atopic dermatitis. J Dermatol Sci. 1996;12:219–26.CrossRefPubMedGoogle Scholar
  39. 39.
    Murota H, El-latif MA, Tamura T, Amano T, Katayama I. Olopatadine hydrochloride improves dermatitis score and inhibits scratch behavior in NC/Nga mice. Int Arch Allergy Immunol. 2010;153:121–32.CrossRefPubMedGoogle Scholar
  40. 40.
    Tominaga M, Ogawa H, Takamori K. Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis. Br J Dermatol. 2008;158:842–4.CrossRefPubMedGoogle Scholar
  41. 41.
    Takamatsu H, Takegahara N, Nakagawa Y, Tomura M, Taniguchi M, Friedel RH, Rayburn H, Tessier-Lavigne M, Yoshida Y, Okuno T, Mizui M, Kang S, Nojima S, Tsujimura T, Nakatsuji Y, Katayama I, Toyofuku T, Kikutani H, Kumanogoh A. Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. Nat Immunol. 2010;11:594–600.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B. IL31: a new link between T cell and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;117:411–7.CrossRefPubMedGoogle Scholar
  43. 43.
    Murota H, Abd El-latif M, Tamura T, Katayama I. Olopatadine hydrochloride decreases tissue interleukin-31 levels in an atopic dermatitis mouse model. Acta Derm Venereol. 2014;94:78–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S. Essential role of Stat6 in IL-4 signaling. Nature. 1996;380:627–30.CrossRefPubMedGoogle Scholar
  45. 45.
    Kaneda Y, Iwaki K, Uchida T. Introduction of the human insulin gene in adult rat liver. J Biol Chem. 1989;264:12126–9.PubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Ichiro Katayama
    • 1
    Email author
  • Kohsuke Yamaga
    • 1
  • Hiroyuki Murota
    • 1
  1. 1.Department of Dermatology, Course of Integrated Medicine, Graduate School of MedicineOsaka UniversityOsakaJapan

Personalised recommendations